Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Medtronic files the 1st module of a pre-market approval application with the FDA for its In.Pact Admiral drug-eluting balloon to treat peripheral artery disease. Medtronic (NYSE:MDT) applied for pre-market approval from the FDA for a medical device designed to treat peripheral artery disease, the In.Pact Admiral drug-eluting balloon. Fridley, Minn.-based Medtronic said it’s gearing up for a full launch in the U.S. in 2015, assuming the FDA approves the application.
Help employers find you! Check out all the jobs and post your resume.
